You are here

Mobile-phone integrated rapid diagnostic tests to improve antibiotic stewardship

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R41AI148088-01
Agency Tracking Number: R41AI148088
Amount: $151,894.00
Phase: Phase I
Program: STTR
Solicitation Topic Code: NIAID
Solicitation Number: PA18-575
Timeline
Solicitation Year: 2018
Award Year: 2019
Award Start Date (Proposal Award Date): 2019-07-01
Award End Date (Contract End Date): 2021-02-28
Small Business Information
1501 9TH AVE N, Nashville, TN, 37208-2109
DUNS: 080703848
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 THOMAS SCHERR
 (443) 386-3232
 tscherr@pragmadx.com
Business Contact
 THOMAS SCHERR
Phone: (443) 386-3232
Email: tscherr@pragmadx.com
Research Institution
 VANDERBILT UNIVERSITY
 110 21 ST. AVE. SOUTH
NASHVILLE, TN, 37203
 Nonprofit college or university
Abstract
PROJECT SUMMARYAn estimatedbillion antibiotic prescriptions were filled in the US fromDespite a national antibiotic education campaignapproximatelyof antibiotic prescriptions are unnecessaryAs a result of the over prescription of antibioticsthere is a current and pressing public health need for improved antibiotic stewardshipCompounding this problem are new modalities of healthcare like telemedicine thatwhile meeting patient demand for conveniencehave been shown to have higher antibiotic prescription ratesAs a resultthere is a pressing need for a tool that these remote providers can use to distinguish between bacterial infectionswhere antibiotics can be effectiveand viral infections where antibiotics are unneededIn this researchwe propose the development of Barcode Embedded Rapid DiagnosticsBERDsas a point of care test to measure a host biomarker signature in response to an infection in bloodThese tests have novel spatial patterning of reagents that allows them to automatically and quantitatively be analyzed by a mobile phone applicationOnce the biomarkers have been analyzed on the testa clinical decision support engine developed in this proposal will provide a confident diagnosisWe have assembled an interdisciplinary consortium that consists of biomedical engineeringpoint of care deviceand software development expertise through PragmaDxIncand biomarker assay development in the Department of Chemistry at Vanderbilt UniversityTo meet our shared goalsour specific aims willoptimize manufacturing conditions of BERDsdevelop and evaluate a machine learning clinical decision support engineand rigorously compare the performance of BERDs to standard clinical laboratory methods using de identified patient specimensA successful outcome of this Phase I STTR will be the development of a diagnostic test and clinical decision support engine that is capable of measuring multiple biomarkers in blood to differentiate the etiology of an infection at the point of carewith accuracy comparable to standard clinical laboratory assaysUpon completion of this effective demonstrationthe platform will be ready for a large scale clinical evaluation that will be the subject of a Phase II application PROJECT NARRATIVEAn estimatedof antibiotic prescriptions are unnecessaryAs a resultantibiotic resistance has developed into a major public health concernDiagnostic tools that can distinguish between varying etiologies of infection are necessary to curb this growing problem

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government